Gynecologic Cancer
Conference Coverage
Study suggests keto diet increases tumor growth in ovarian cancer
Conducted in mouse models, this study contradicts other studies that show tumor-suppressing effects.
Conference Coverage
AI model predicts ovarian cancer responses
Model achieves overall accuracy of 93% using still-frame images.
Conference Coverage
Asking hard questions during office visits can improve patient outcomes
Improving outcomes among a small group of Black patients came down to asking questions doctors wouldn’t ordinarily ask.
From the Journals
Obesity increasing the risk for cancer: It’s complicated
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
Conference Coverage
Symptoms, not pelvic exams, pick up most endometrial cancer recurrences
The findings speak to the anxiety of shifting to telemedicine during COVID-19.
Conference Coverage
Complex surgery 10 times more likely with some ovarian tumors
Imaging, tumor subtype predict debulking success in advanced ovarian cancer.
Clinical Review
2022 Update on gynecologic cancer
Highlights from 4 medical and surgical trials on gynecologic cancers and what their results may mean for patient-focused outcomes...
Gynecologic Oncology Consult
The medical management of early-stage endometrial cancer: When surgery isn’t possible, or desired
Hormonal therapy has long been identified as a highly effective systemic therapy for endometrial cancers, particularly those that are low grade...
From the Journals
Virtual exams for routine surveillance after ovarian cancer
The pandemic has accelerated the use of telemedicine. The investigators wondered how it would work in patients who have achieved remission from...
Latest News
Researchers identify growing racial disparity in endometrial cancer mortality
The 5-year relative survival rate for Black women is 63%, compared with 84% for White women – a 21% gap in absolute terms.
Gynecologic Oncology Consult
Optimizing ‘optimal’ in ovarian cancer cytoreduction
While pafolacianine promises to move us closer to a true “R0” (negative margins) resection of ovarian cancer, is this even a feasible goal in a...